Back

Comparison of major adverse cardiovascular events between sacubitril-valsartan versus ACEI/ARB therapy in patients with heart failure with reduced ejection fraction

18 March 2022 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: e-Posters session Epidemiology, Prognosis, Outcome ACVC Premium Access ESC Acute CardioVascular Care 2022

About the speaker

Photo
Doctor Mariana Tinoco

Alto Ave Hospital Center, Guimaraes (Portugal)

90 More presentations in this session

Presentation thumbnail
Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention
Doctor D. Zahler (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Clinical utility of the SCAI classification in cardiogenic shock patients of any etiology treated by a multidisciplinary team.
Miss S. Lozano Jimenez (Majadahonda, ES)
Abstract Slides
Presentation thumbnail
Heart failure correction in patients with chronic renocardiac syndrome
Mr A. Demikhov (Sumy, UA)
Abstract Slides
Presentation thumbnail
Features of vascular motor endothelial function in hypertensive patients with chronic heart failure
Mr A. Demikhov (Sumy, UA)
Abstract Slides
Presentation thumbnail
Correlation of cholesterol efflux capacity with femoral and carotid plaque volume measured by sonographic 3D plaque volumetry
Doctor M. Noflatscher (Innsbruck, AT)
Abstract Slides

Access the full session

Session thumbnail
e-Posters session

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March 2022 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources